Hazard identification involves determining whether a nanomaterial has the inherent capability to cause adverse effects. This can be achieved through various toxicological studies, including in vitro and in vivo tests. Special attention should be given to the unique properties of nanomaterials that may not be present in their bulk counterparts.
